On January 20, 2025, President Donald Trump signed an executive order initiating the United States’ withdrawal from the World Health Organization (WHO). This action sets a 12-month notice period during which the U.S. will cease financial contributions and reassign federal personnel associated with the WHO.
What U.S. Leaving the WHO could mean for Clinical Research?
The U.S. will undoubtedly reduce its financial contributions and collaboration with the WHO compared to the level of support provided so far.
This could also impact What It Means for Clinical Trials Worldwide
Loss of U.S. funding for global health initiatives.
Regulatory misalignment with WHO standards.
Potential delays in international data sharing.
How This Affects the EU:
Pressure to fill the financial gap in WHO programs.
Challenges in harmonizing U.S. and WHO regulatory frameworks.
Opportunities for the EU to lead global health initiatives.
Multinational research needs to adapt to new standards.
The EU should strengthen its leadership role in global health.
Collaboration is more vital than ever.
How do you think the U.S. exit from the WHO will impact Clinical Research and EU?
Leave a Reply